Pfizer Shares Buoyed by Naproxen Warning
48641
Pfizer stock closed at $25.95, rising 4 percent. The stock began a rally earlier in the week on word that the US Food and Drug Administration had issued a warning of potential heart problems for naproxen.
225639
Pfizer Inc. PFE.N , the world's  largest drug company, on Wednesday said fourth-quarter earnings  rose, helped by strong sales of cholesterol treatment Lipitor  and other medicines.
730264
U.S. health regulators warned on  Monday of heart risks connected to over-the-counter painkiller  naproxen, a further blow to patients seeking pain relief that  creates additional confusion over the safety of similar drugs  after recent warnings for two other painkillers.
362559
Drug investors may be wishing they could pop two pills and feel better in the morning. The latest headache hit last week when Pfizer joined the rash of drug companies announcing problems with their products.
726208
Pfizer Inc.   raised its 2006 profit forecast on Thursday and said  its roster of experimental drugs in late-stage testing could  triple by 2009, sending its shares higher.
51615
Another shock hit the drug sector Friday when pharmaceutical giant Pfizer Inc. announced that it found an increased heart risk to patients for its blockbuster arthritis drug Celebrex.
599967
New prescriptions for Pfizer Inc.'s  arthritis drug Celebrex fell 56 percent last week after the  company released data showing the drug may increase the risk of  heart attacks and strokes, the Wall Street Journal said.
764151
NEW YORK (Dow Jones/AP) -- Pfizer Inc. defended the safety of its painkiller Celebrex on Thursday after a newspaper reported that documents from Canadian health authorities linked the drug to the deaths of
130664
The drug maker stops advertising Celebrex, but says it won&#39;t pull the drug from the market. Oil dips below $46 per barrel. Stocks are indicated to open higher today, but trading could be subdued this holiday-shortened week.
535922
Prudential Equity Group maintained a &quot;neutral weight&quot; rating on Pfizer (nyse: PFE - news - people ) after Canadian news reports surfaced linking its arthritis drug Celebrex with cardiovascular side effects.
130323
BEIJING, Dec. 24 -- FDA has recommended on Thursday that doctors and users are cautious to use the controversial painkillers -- Pfizer Inc.
484469
Pfizer Inc. shares rebounded on  Tuesday as a study of Alzheimer's patients found that its  arthritis drug Celebrex carried no increased cardiovascular  risks, differing from findings of a study in cancer patients  released last week.
148326
NEW YORK - At the end of Pfizer&#39;s annual analyst meeting, Chief Executive Hank McKinnell dropped a bombshell. Older, over-the-counter pain medicines may not be safe for the heart, McKinnell said, because there
758212
As Pfizer&#39;s (PFE:NYSE - news - research) Celebrex safety hiccup was unfolding Friday, I had a running conversation with a fund manager.
372604
The news that one of Bayer's over-the-counter painkillers may increase the risk of heart attacks and strokes barely fazed shareholders.
643296
NEW YORK  - Drugs giant Pfizer Inc.&#39;s stock fell on a report that prescriptions for its blockbuster pain medication Celebrex slumped 56 percent last week.
45984
Drug company Pfizer said today it is continuing to promote its arthritis drug Celebrex to doctors despite reports it more than doubles the risk of heart attacks and strokes.